We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Neurophos Stock

Invest in or calculate the value of your shares in Neurophos or other pre-IPO companies through EquityZen's platform.

Get Started

Neurophos Stock

Neurophos develops photonic AI processing technology that focuses on hardware solutions for accelerating artificial intelligence inference.

About Neurophos Stock

Founded

2020

Headquarters

Austin, TX, US

Industries

Software, Artificial Intelligence, Data and Analytics

Neurophos develops photonic AI processing technology that focuses on hardware solutions for accelerating artificial intelligence inference by replacing traditional electronic compute elements with optical processing units (OPUs). The company’s technology uses ultra-dense optical modulators and silicon photonics to enable computation using light, aiming to support matrix operations central to AI workloads with increased energy efficiency and performance relative to conventional graphics processing units. Neurophos’ offerings include prototype OPUs and development systems designed to integrate into data center environments, and its platform targets engineering teams and compute-intensive applications that demand scalable AI inference capability. The business collaborates with industry partners and investors to advance its optical compute architecture and develop supporting software stacks and hardware modules for deployment. Neurophos also engages in pilot programs and partnerships to test its photonic processors in real-world compute environments and explore integration pathways with existing infrastructure. Its work leverages research in metamaterials and compute-in-memory design to reduce power consumption and enhance throughput for AI inference tasks.

Neurophos Management

Leadership team at Neurophos

CEO and Co-Founder

Patrick Bowen

Member of Technical Advisory Board

Ty Garibay

Locked Features

Join now and verify your accreditation status to gain access to:

  • Neurophos Current Valuation
  • Neurophos Stock Price
  • Neurophos Management
  • Available deals in Neurophos and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Neurophos Cap Table and Funding History by Share Class and Liquidity Preferences
    • Neurophos Revenue and Financials
    • Neurophos Highlights
    • Neurophos Business Model
    • Neurophos Risk Factors
  • Neurophos Research Report from SACRA Research
Join Now

Trading Neurophos Stock

How to invest in Neurophos stock?

Accredited investors can buy pre-IPO stock in companies like Neurophos through EquityZen funds. These investments are made available by existing Neurophos shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.

How to sell Neurophos stock?

Shareholders can sell their Neurophos stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."

More Like Neurophos